PCVXVaxcyte, Inc.
$60.39+39% 1Y
$60.39
$40.3252 weeks$71.34
The financials
Vaxcyte, Inc. by the numbers
The next results filing is expected around Nov 3, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$303M | −$226M | n/a |
| Net income | −$284M | −$167M | n/a |
| Diluted EPS | −$1.97 | −$1.22 | n/a |
On our screens:Most shorted stocks